General Information of Drug (ID: DR1793)
Drug Name
LF-08-0299
Synonyms
LF 08-0299; LF-08-0299; SCHEMBL385624; Tresperimus; Tresperimus [INN:BAN]; ZINC3806041; (4-((3-Aminopropyl)amino)butyl)carbamic acid, ester with N-(6-guanidinohexyl)glycolamide; (4-((3-aminopropyl)amino)butyl)-2-((6-((aminoiminomethyl)amino)hexyl)amino)-2-oxoethyl carbamic acid ester; 160677-67-8; 286F595V8H; AC1MJ6LW; CHEMBL98034; Carbamic acid, (4-((3-aminopropyl)amino)butyl)-, 2-((6-((aminoiminomethyl)amino)hexyl)amino)-2-oxoethyl ester; DTXSID50166968; UNII-286F595V8H
Indication Diabetes mellitus [ICD11: 5A10] Discontinued [1]
Structure
3D MOL is unavailable 2D MOL
Pharmaceutical Properties Molecular Weight 387.5 Topological Polar Surface Area 170
Heavy Atom Count 27 Rotatable Bond Count 18
Hydrogen Bond Donor Count 6 Hydrogen Bond Acceptor Count 6
Cross-matching ID
PubChem CID
3086680
CAS Number
160677-67-8
TTD Drug ID
D0K0ZB
Formula
C17H37N7O3
Canonical SMILES
C(=N)(NCCCCCCNC(=O)COC(=O)NCCCCNCCCN)N
InChI
1S/C17H37N7O3/c18-8-7-10-21-9-5-6-13-24-17(26)27-14-15(25)22-11-3-1-2-4-12-23-16(19)20/h21H,1-14,18H2,(H,22,25)(H,24,26)(H4,19,20,23)
InChIKey
LVBMFPUTQOHXQE-UHFFFAOYSA-N
The Metabolic Roadmap of This Drug
The Full List of Drug Metabolites (DM) of This Drug
DM Name DM ID PubChem ID Reaction DM Level REF
LF-08-0299 M1 DM006913 N. A. Unclear 1 [2]
LF-08-0299 M6 DM006917 N. A. Hydrolysis - Hydrolysis 1 [2]
LF-08-0299 M7 DM006919 N. A. Hydrolysis - Hydrolysis 1 [2]
LF-08-0299 M2 DM006920 N. A. Unclear 2 [3]
LF-08-0299 M3 DM006914 N. A. Oxidation - Deamination 2 [3]
LF-08-0299 M4 DM006915
154731592
Unclear 3 [2]
LF-08-0299 M6 DM006917 N. A. Oxidation - Deamination 3 [3]
LF-08-0299 M7 DM006919 N. A. Unclear 3 [2]
LF-08-0299 M5 DM006916
154731636
Unclear 4 [2]
LF-08-0299 M8 DM006918
81176
Unclear 4 [2]
LF-08-0299 M8 DM006918
81176
Oxidation - Deamination 4 [3]
⏷ Show the Full List of 11  DM(s)
The Full List of Metabolic Reaction (MR) of This Drug
MR ID Reactant Product MR Type DME REF
MR007524 LF-08-0299 LF-08-0299 M1 Unclear AOC2 [2]
MR007533 LF-08-0299 LF-08-0299 M6 Hydrolysis - Hydrolysis Unclear [2]
MR007534 LF-08-0299 LF-08-0299 M7 Hydrolysis - Hydrolysis Unclear [2]
MR007525 LF-08-0299 M1 LF-08-0299 M3 Oxidation - Deamination Unclear [3]
MR007532 LF-08-0299 M1 LF-08-0299 M2 Unclear Unclear [3]
MR007526 LF-08-0299 M3 LF-08-0299 M4 Unclear Unclear [2]
MR007528 LF-08-0299 M3 LF-08-0299 M6 Oxidation - Deamination Unclear [3]
MR007530 LF-08-0299 M3 LF-08-0299 M7 Unclear ALDH [2]
MR007527 LF-08-0299 M4 LF-08-0299 M5 Unclear Unclear [2]
MR007529 LF-08-0299 M6 LF-08-0299 M8 Oxidation - Deamination AOC2 [3]
MR007531 LF-08-0299 M7 LF-08-0299 M8 Unclear AOC2 [2]
⏷ Show the Full List of 11 MR(s)
Drug-Metabolizing Enzyme(s) (DME) Metabolizing This Drug
DME Name DME Info Species Uniprot ID EC Number REF
Aldehyde dehydrogenase (ALDH) DMEN076 . Not Available Not Available [2]
Copper amine oxidase (AOC3) DME0405 Homo sapiens
AOC3_HUMAN
1.4.3.21
[2]
References
1 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800004804)
2 Metabolism of tresperimus by rat aorta semicarbazide-sensitive amine oxidase (SSAO). Fundam Clin Pharmacol. 2002 Dec;16(6):461-70.
3 Involvement of semicarbazide-sensitive amine oxidase in tresperimus metabolism in human and in rat

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.